Biogen signs lease for Kendall Common as part ... footprint New building will be designed to foster collaboration and spark innovation; Biogen plans to relocate Cambridge-based employees to ...

“Biogen has been a foundational presence in the Massachusetts life science ecosystem for close to half a century,” said Governor Maura Healey, in a statement. “We are thrilled to see them ...

SAN FRANCISCO (Reuters) - Biogen expects revenue from new launches to exceed its current sales by 2028 and does not feel the need to chase additional business development deals, the company's CEO ...

We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis ...

For more than 20 years, Biogen employees have volunteered through our Community Labs to spark local student interest in science and biotechnology and help create pathways for young adults to careers ...

Biogen has announced it will give up ownership and halt sales of Aduhelm, an embattled Alzheimer's disease drug that was scrutinized following its 2021 approval. Biogen said it terminated a ...

Biogen is officially pivoting away from Aduhelm, the first Alzheimer's treatment the Cambridge drugmaker made. Biogen said over the past year it looked for potential partners or external financing ...

Nov 8 (Reuters) - (This Nov. 8 story has been corrected to say Biogen cut profit forecast due to costs related to a deal, not the launch of its Alzheimer's drug, in paragraph 1 and the headline ...

It was only last spring that Biogen started a round of layoffs that eventually shrank the company’s head count by nearly 900 people last year. Now, a fresh round of job cuts targeting 1,000 ...

The biotech company Biogen is revamping its board of directors. A nominee is in a romantic relationship with a departing director that wasn't publicly disclosed. The nominee, Susan Langer ...

Biogen has been a top dog in the multiple sclerosis ... Bionews, and are intended to spark discussion about issues pertaining to multiple sclerosis.